Garlic (Allium sativum L.) and cardiovascular diseases

Bratislava Medical Journal

Volumn 111, Issue 8, 2010, Pages 452-456

  Ginter, E ^a   Simko, V ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Antioxidant effects; Blood pressure; Cardiovascular diseases; Garlic; Hydrogen sulfide; Platelet aggregation

Indexed keywords

ANTIOXIDANT; PLANT EXTRACT;

ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; GARLIC; HUMAN; LIPID METABOLISM; REVIEW;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; GARLIC; HUMANS; LIPID METABOLISM; PLANT EXTRACTS;

EID: 77956910771     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Gebhardt R, Beck H. Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures. Lipids 1996; 31: 1269-1276.
2. U.S. Department of Health and Human Services, National Institutes of Health, 2008. Bethesda, USA.
3. Liu L, Yeh YY. S-alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes. J Nutr 2002; 132 (6): 1129-1134.
4. Singh DK, Porter TD. Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J Nutr 2006; 136 (Suppl 3): 759S-764S.
5. Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. J Am Acad Nurse Pract 2003; 15: 120-129.
6. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001; 161: 813-824.
7. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000; 133: 420-429.
8. Kannar D, Wattanapenpaiboon N, Savige GS, Wahlqvist ML. Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutr 2001; 20: 225-231.
9. Gardner CD, Chatterjee LM, Carlson JJ. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001; 154: 213-220.
10. Turner B, Molgaard C, Marckmann P. Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2004; 92: 701-706.
11. Gardner CD, Lawson LD, Block E et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007; 167: 346-353.
12. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr 2006; 136: 736S-740S.
13. Rahman K. Historical perspective on garlic and cardiovascular disease. J Nutr 2001; 131: 977S-979S.
14. Ashraf R, Aamir K, Shaikh AR, Ahmed T. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub Med Coll Abbottabad 2005; 17: 60-64.
15. Duda G, Suliburska J, Pupek-Musialik D. Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults. Pharmacol Rep 2008; 60: 163-170.
16. Durak I, Kavutcu M, Aytac B, Avci A et al. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem 2004; 15: 373-377.
17. Dhawan V, Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem 2005; 275: 85-94.
18. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Dis 2008; 8: 13. doi: 10.1186/1471-2261-8-13.
19. Benavides GA, Squadrito GL, Mills RW et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 2007; 104: 17977-17982.
20. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA 2007; 104: 17907-17908.
21. Elrod JW, Calvert JW, Morrison J et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-15565.
22. Lau BHS. Recent advances on the nutritional effects associated with the use of garlic as a supplement suppression of LDL oxidation by garlic. J Nutr 2001; 131: 85S-988S.
23. Lei YP, Chen HW, Sheen LY, Lii CK. Diallyl disulfide and diallyl trisulfide suppress oxidized LDL-induced vascular cell adhesion molecule and E-selectin expression through protein kinase A-and B-dependent signaling pathways. J Nutr 2008; 138: 996-1003.
24. Dhawan V, Jain S. Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension. Mol Cell Biochem 2004; 266: 109-115.
25. Tapiero H, Townsend DM, Tew KD. Organosulfur compounds from alliaceae in the prevention of human pathologies. Biomed Pharmacother 2004; 58: 183-193.
26. Huang CN, Horng JS, Yin MC. Antioxidative and antiglycative effects of six organosulfur compounds in low-density lipoprotein and plasma. J Agric Food Chem 2004; 52: 3674-3678.
27. Ou CC, Tsao SM, Lin MC, Yin MC. Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic. Lipids 2003; 38: 219-224.
28. Dillon SA, Burmi RS, Lowe GM, Billington D, Rahman K. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein. Life Sci 2003; 72: 1583-1594.
29. Ide N, Lau BH. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kappa b activation. J Nutr 2001; 131 (3s): 1020S-1026S.
30. Stoll G, Bendszus M. Inflammation and atherosclerosis. Stroke 2006; 37: 1923-1932.
31. Milioti N, Bermudez-Fajardo A, Penichet ML et al. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Clin Dev Immunol 2008; 2008. doi: 10.1155/2008/723539.
32. Gorinstein S, Jastrzebski Z, Namiesnik J et al. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res 2007; 51: 1365-1381.
33. Keiss HP, Dirsch VM, Hartung T, Haffner T et al. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappaB activity. J Nutr 2003; 133: 2171-2175.
34. Kim KM, Chun SB, Koo MS, Choi WJ et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med 2001; 30: 747-756.
35. Ali M, Thomson M, Afzal M. Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance. Prostaglandins Leukot Essent Fatty Acids 2000; 62: 55-73.
36. Dirsch VM, Kiemer AK, Wagner H, Vollmar AM. Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase. Atherosclerosis 1998; 139: 333-339.
37. Chang HP, Huang SY, Chen YH. Modulation of cytokine secretion by garlic oil derivatives is associated with suppressed nitric oxide production in stimulated macrophages. J Agric Food Chem 2005; 53: 2530-2534.
38. Chan KC, Hsu CC, Yin MC. Protective effect of three diallyl sulphides against glucose-induced erythrocyte and platelet oxidation, and ADP-induced platelet aggregation. Thromb Res 2002; 108: 317-322.
39. Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000; 130: 2662-2665.
40. Ferri N, Yokoyama K, Sadilek M et al. Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation. Br J Pharmacol 2003; 138: 811-818.
41. Golovchenko I, Yang CH, Goalstone ML, Draznin B. Garlic extract methylallyl thiosulfmate blocks insulin potentiation of platelet-derived growth factor-stimulated migration of vascular smooth muscle cells. Metabolism 2003; 52: 254-259.
42. Budoff MJ, Takasu J, Flores FR et al. Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med 2004; 39: 985-991.
43. Budoff M. Aged garlic extract retards progression of coronary artery calcification. J Nutr 2006;136 (Suppl 3): 741S-744S.
44. Zhu Y, Inayaki K, Haraguchi H et al. Determination and size-fractional distribution of the elements in garlic. Anal Sci 2009; 25: 137-140.
45. Chandraskehar PM, Venkatesh YP. Identification of the protein components displaying immunomodulatory activity in aged garlic extract. J Ethnopharmacol 2009; E-pub.
46. Jimenez-Monral AM, Garcia-Diaz L, Martinez-Tome M et al. Influence of cooking methods on antioxidant activity vegetables. J Food Sci 2009; 74: H97-H103.